局限性脱发区域隐形和对托法西提尼布的反应
Mayra A Reyes Soto1, Rodrigo Pirmez2
1Department of Dermatology, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Skin appendage disorders
|February 6, 2025
概括
隐形白发症 (Alopecia areata incognita,简称AAI) 是一个备受争议的疾病. 当皮质类固醇失败时,一种罕见的有限的AAI变异被口服托法西提尼布成功治疗,这表明了新的治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 三学是指三学的学科.
背景情况:
- 隐形白发症 (Alopecia areata incognita,简称AAI) 是一个备受争议的脱发症.
- 局限性AAI,局部变种,很少被记录.
研究的目的:
- 报告一个不寻常的局限性AAI病例.
- 为了评估口服托法西提尼布在耐火病例中的疗效.
主要方法:
- 一名21岁的女性有局限的AAI接受了口服托法西提尼布5毫克每天两次的治疗.
- 通过三镜检查证实了诊断,显示了典型的AAI特征.
主要成果:
- 患者对口服托法西提尼布有持续的积极反应.
- 像德克萨米他这样的传统治疗导致复发和体重增加.
结论:
- 口服托法西提尼布是对对皮质类固醇无反应的AAI病例的潜在治疗选择.
- 这一案例突显了托法西提尼布在耐火局限性AAI中的疗效.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
T Cell Types and Functions
939
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
939
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464


